silex systems limited investor update

Silex Systems Limited

Investor update (ASX: SLX) (OTCQX: SILXY)

Dr Michael Goldsworthy, CEO / Managing Director

August/September 2014

© Silex Systems Limited 2014

For

per

sona

l use

onl

y

Forward Looking Statements

Silex Systems is a research and development Company whose assets are its proprietary rights in various technologies, including, but

not limited to, the SILEX technology, Solar Systems technology and business, Translucent technology and ChronoLogic technology.

Several of the Company’s technologies are in the development stage and have not been commercially deployed, and therefore are

high-risk. Accordingly, the statements in this presentation regarding the future of the Company’s technologies and commercial

prospects are forward looking and actual results could be materially different from those expressed or implied by such forward looking

statements as a result of various risk factors.

Some risk factors that could affect future results and commercial prospects include, but are not limited to: results from the SILEX

uranium enrichment commercialisation program; the demand for enriched uranium; the risks associated with the development of

Solar Systems technology and related marketing activities; the outcomes of the Company’s interests in the development of various

semiconductor, photonics, instrumentation and alternative energy technologies; the time taken to develop various technologies; the

development of competing technologies; the potential for third party claims against the Company’s ownership of Intellectual Property

associated with its numerous technologies; the potential impact of government regulations or policies; and the outcomes of various

commercialisation strategies undertaken by the Company. Accordingly, the inclusion of forward looking information in this

presentation should not be regarded as a representation or warranty with respect to its accuracy or the accuracy of the underlying

estimates or assumptions or that Silex will achieve or is likely to achieve any particular results.

The forward looking statements included in this presentation involve subjective judgment and analysis and are subject to significant

business, economic and competitive uncertainties, risks and contingencies, many of which are outside the control of, and are

unknown to Silex. Given these uncertainties, you are cautioned to not place undue reliance on such forward looking statements.

P2


For

per

sona

l use

onl

y

Disclaimer

Silex Systems Ltd (Silex) has prepared this presentation based on information available to it. The information in this presentation

does not purport to be a complete description of Silex and/or its various business activities. Except as required by law, no

representation or warranty, express or implied, is made by Silex as to the fairness, accuracy, completeness or correctness of the

information, opinions and conclusions contained in this document and discussed in the presentation, or as to the reasonableness of

any assumption contained in this presentation. By receiving or viewing this presentation and to the extent permitted by law, you

release Silex and its directors, officers, employees, agents and affiliates from any liability (including, without limitation, in respect of

direct, indirect or consequential loss or damage, or loss or damage arising by negligence) arising as a result of the reliance by you or

any other person on anything contained in or omitted from this presentation.

This presentation should be read in conjunction with other disclosures that have been lodged by the company with the Australian

Stock Exchange.

No responsibility is accepted by Silex or any of its directors, officers, employees, agents or affiliates, nor any other person, for any of

the information contained in this document and discussed in the presentation or for any action taken by you on the basis of the

information or opinions expressed in the course of this presentation. This presentation does not constitute investment, legal, taxation

or other advice and the presentation does not take into account your investment objectives, financial situation nor particular needs.

You are responsible for forming your own opinions and conclusions on such matters and should make your own independent

assessment of the information contained in this document and discussed in the presentation and seek independent professional

advice in relation to such information and any action taken on the basis of the information.

This document is not a product disclosure statement or prospectus for the purposes of the Australian Corporations Act 2001 and does

not constitute an offer, invitation, solicitation or recommendation in relation to the subscription, purchase or sale of shares or other

securities in any jurisdiction, including in the United States or to any U.S. person, and neither this document nor anything in it shall

form the basis of any contract or commitment. Securities may not be offered or sold in the United States, or to or for the account of

any U.S. person, unless the securities have been registered under the U.S. Securities Act of 1933 or an exemption from registration is

available.

P3


For

per

sona

l use

onl

y

The Company

P4

Silex Systems is a unique technology company,

focusing on the development and

commercialisation of its innovative and

potentially disruptive laser-based

SILEX uranium enrichment technology.


For

per

sona

l use

onl

y

Silex Systems Strategic Review

• Strategic review of entire business undertaken by Board in response to recent adverse market

conditions, with results announced 30th June 2014

• Key decision – to return the primary focus of the company to the development and

commercialisation of our foundation technology – the SILEX laser uranium enrichment technology

• Resulted in the cessation of Chronologic operations, although efforts are continuing to achieve an

IP license or sale with third parties

• Strategies aimed at accelerating transition to market for Translucent and Solar Systems currently

being implemented, with a focus on securing value-creating transactions with partners or investors

• Restructure will deliver a significant reduction in cash burn across the company in FY 2015

• Medium to long term outlook for the global nuclear industry indicates a return to strong growth

• Focus on the SILEX technology deemed to be the best path forward to return value to shareholders

P5


For

per

sona

l use

onl

y

Major Strategic Review - Overview

ChronoLogic

• Cessation of operations completed in July 2014

• Significant patent portfolio established in recent years

• Efforts continue to achieve IP license or sale

Translucent

• Priority is to pursue an accelerated path to commercialisation

• Focus on value creating transaction – sale or partnership

• Aim to minimise parent company investment in FY 2015

Solar Systems • Accelerated business development efforts to secure strategic partner

or equity investor during FY 2015

• Aim to minimise need for parent company investment

• Product development focus on reducing levelised cost of energy (LCOE)


P6

For

per

sona

l use

onl

y

Solar Systems CPV Dish Technology

P7

Two Concentrating Photovoltaic (CPV) Dish Solar Power

Stations built and operated:

1. Mildura, Australia (~1.5MW, 40 dishes) opened in July 2013

• Solar Systems is exploring additional options to further

develop the site and other potential sites in Australia

2. Nofa Resort, Saudi Arabia (~1MW, 28 dishes) completed

in April 2014

• Saudi Arabia is a key emerging market with plans to invest

heavily in solar energy - $US109 billion program to help

replace domestic oil consumption


Nofa Resort solar power station

Solar Systems continues to prepare its unique ‘Dense Array’ CPV dish product for

market as it seeks a strategic partner or investor

For

per

sona

l use

onl

y

Translucent – Novel Semiconductor Substrate Materials • Translucent’s next generation semiconductor materials being prepared

for application to power electronics and ultra-high efficiency solar cells

• Materials include ‘Rare Earth Oxides’ (REO’s) which aim to enable

low cost “on-silicon” solutions scalable to 200mm wafers

• Business development activities and industry validation by third parties

continues to generate commercial interest

• Translucent is currently engaging with potential customers and

strategic partners to accelerate the path to market

• Equity investment/divestment options being considered with aim of

minimising parent funding in FY 2015

P8


Above: Translucent epiwafers

GaN-on-Si for power electronics

Ge-on-Si for multi-junction solar cells

Epiwafer products

For

per

sona

l use

onl

y

SILEX Laser Uranium Enrichment Technology


For

per

sona

l use

onl

y

Advantages of the SILEX Technology

Mine uranium

Convert to UF6

Enrich uranium

Fabricate fuel

Use in reactor

Produce electricity

• Enrichment is the most difficult and costly step in making nuclear fuel for power reactors

(~35% to 40% of total cost)

• SILEX is a breakthrough in efficiency – most cost effective enrichment method

• Anticipated to have the lowest capital costs of all enrichment technologies

• Smaller footprint than centrifuge and diffusion plants

• The only 3rd generation laser-based enrichment technology in the world

• Classified technology - protected by the strictest security measures

P10

Nuclear Fuel Production © Silex Systems Limited 2014

For

per

sona

l use

onl

y

Commercialisation and License Agreement

P11

Perpetual Royalty Agreement with Global Laser Enrichment (GLE)

51% 25% 24%

Worldwide License Royalties

• Exclusive worldwide commercialisation and license agreement for

the SILEX Technology – signed in 2006

• GLE funding of commercialisation program - based in

Wilmington, North Carolina

• Phase I milestone completed in May 2013 – triggered US$15

million payment to Silex

• Next milestone payment triggered by start of construction of initial

commercial plant: US$5 million

• Final milestone payment – US Nuclear Regulatory Commission

(NRC) verification of construction compliance of initial commercial

plant: US$15 million

• Perpetual royalty range of 7 - 12% of future GLE

revenues from commercial operations (based on calculation of cost per unit production installed)


For

per

sona

l use

onl

y

GLE’s Phased Approach to Commercialisation

GLE restructure announced on 24th July 2014

• GLE announced changes to the funding and pace of the

commercialisation program to align with adverse market conditions

• Key commercial terms in the license agreement have not changed -

royalty structure remains unchanged

• Phase II activities (refer below) consolidated in Wilmington, NC.

P12


Phase Objectives Status

Phase I: Test Loop technology demonstration and NRC commercial plant license approval Completed

Phase II: Economic and engineering validation for the initial commercial production module Commenced in 2012

Phase III: Construction of the first full-scale commercial production facility Yet to commence

For

per

sona

l use

onl

y

P13

Paducah Enrichment Plant Opportunity Update

Negotiations between GLE and the DOE continue

Paducah Enrichment Plant Site

• Closure of existing 1st generation gaseous diffusion

plant in May 2013 – led to Department of Energy

(DOE) bid process for future operations.

• GLE submitted a proposal to the DOE in August 2013

involving construction of a SILEX-based laser

enrichment plant at the Paducah site.

• DOE selected the GLE proposal exclusively in

November 2013 for possible future commercial

operations at Paducah.

• Enrichment of DOE tails stockpiles potentially

equivalent to one of the largest uranium mines in the

world operating for around 40 years.

• Plans will ultimately depend on a recovery in uranium

market pricing from currently depressed levels

• Negotiations between the GLE and DOE continue


For

per

sona

l use

onl

y

Nuclear Energy Market Outlook P14

Source: World Nuclear Association (WNA) – August 2014.

Global Nuclear Capacity to Increase Significantly

• Likely potential for doubling in nuclear capacity from 435 plants today to ~ 900 plants in 2030

(allowing for some closures of older plants, and several Japanese plants likely to be permanently shut down).

11 percent of global electricity

435 operable reactors currently

72 new plants under construction

174 plants planned

299 plants proposed

Key Statistics Key Nuclear Markets – power plants

Country 2014 2030**

TOTAL – all Countries 435 ~900

US 100 ~120

China 20 226

India 21 84

Saudi Arabia / UAE 0 30

Japan 48* ~50

* All 48 operable reactors currently offline

** Assumes most current operable reactors remain in service


For

per

sona

l use

onl

y

Uranium Enrichment Market Outlook

P15

Short Term Market Outlook – ‘Negative’

• Short term market likely to remain depressed due to impact of Japanese industry shutdown

• Japanese reactors - likely to see first restarts later this year - slower than anticipated

• Enrichment prices down ~45%, uranium prices down ~60% since Fukushima

Medium Term Market Outlook – ‘Recovery’

• Medium term highly dependent on several macro factors

o Pace of Japanese reactors restarts

o Potential trade sanctions against Russia (Tenex - world’s largest enrichment player)

o Pace of global nuclear build and influence of environmental drivers

• Potential supply pressures in medium term timeframe – possible opportunity for introduction of SILEX capacity

Long Term Market Outlook – ‘Bullish’

• Potential for nuclear capacity growth of 2x by 2030 (from 435 currently to ~900 plants over next 2 decades)

• Long term – potential for significant increase in uranium enrichment demand within ‘accessible’ market


For

per

sona

l use

onl

y

Why Nuclear Power is Essential to Sustainable Growth

P16

*Sources: Various third party documents and websites. All figures are approximate for purposes of comparison.


Nuclear Coal Gas

Fuel / yr* ~20 tons ~4,000,000 tons ~1,000,000 tons

CO2 Emissions* 0 tons ~6,000,000 tons ~3,000,000 tons

Cost*(LCOE) / MWh

$65 ~ $100 $65 ~ $100 $55 ~ $100

Equivalent 1GWe Power Generation Plants

For

per

sona

l use

onl

y

Silex Core Investment Case

Company is well positioned to execute the major strategic review including a

significant reduction in cash burn during FY 2015 (current cash reserves of ~$60m)

Strategy to accelerate transition to market for subsidiary businesses Solar Systems

and Translucent via value creating transactions – securing partners or investors

Primary asset: the ‘SILEX’ uranium enrichment technology - the only third generation

laser-based enrichment technology in the world

SILEX technology is under licence to Global Laser Enrichment (GLE) - a business

venture of GE (51%), Hitachi (25%) and Cameco (24%)

GLE continues to fund the uranium enrichment commercialisation program – albeit at

a reduced pace in line with adverse short term market factors

Silex will potentially be entitled to a perpetual royalty (of 7 to 12% - depending on

plant capex) on GLE’s uranium enrichment revenues

Potential for capital growth as the global nuclear fuel market recovers and grows

P17


For

per

sona

l use

onl

y

Thank you


For

per

sona

l use

onl

y

silex systems limited investor update

Documents